Famotidine Powder, For Suspension
Product Images NDC 81033-023

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 81033-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kesin Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Famotadine 40 mg/5 mL Bottle Of 50 mL (Famotidinepdp)

Label panel for Famotidine for Oral Suspension, USP 40 mg/5 mL powder for suspension by Kesin Pharma Corporation. It includes instructions for reconstitution by adding 46 mL of water, storage conditions for the dry powder and suspension, usage notes, a barcode, and space for the reconstitution date. The final suspension volume after reconstitution is 50 mL.*

FDA Label Image

Kesin Pharma Logo (Kesin Logo)

FDA Label Image

Chemstructure (Chemstructure)

Chemical structure of famotidine, the active ingredient in the drug FAMOTIDINE. The diagram shows the molecular composition and arrangement of atoms in famotidine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.